Validation of the French Version of Ask Suicide-Screening Questions (ASQ) in Adolescents Managed in Pediatric Emergency Unit
NCT ID: NCT02900989
Last Updated: 2017-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2016-07-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Knowledge About Fever After Consultation in the Pediatric Emergency Department
NCT04925401
Parental Compliance After Telephone Triage Advice During and After Confinement During the COVID-19 Epidemic in France
NCT04656444
Computer-Assisted Self-Interviews and Health Screening in the Pediatric Emergency Department
NCT01708317
Evaluation of Mobile App to Assist in Pediatric Triage
NCT05363124
Fever Infants and Therapeutic Education in Emergency Department
NCT03706599
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ASQ-Fr questionnaire is conducted by a psychologist before or after the French version of the SIQ/SIQ Junior (Suicidal Ideation Questionnaire), depending on the randomisation in the unit. SIQ is composed of 30 items and valid for adolescents aged 15 years or more. SIQ Junior is composed of 15 items and valid for children up to 14 years old.
Questionnaires are followed by an interview in adolescents and parents separately by the psychologist to evaluate perceptions, feasibility and acceptability of questionnaires.
It is planned a convenience sample of 200 patients aged 10 to 18 years who presented with either medical or surgical chief concerns to the emergency department.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ASQ-Fr
Adolescents undergo the ASQ-Fr questionnaire composed of 5 items.
Suicide screening
Patients of the emergency unit usually do not pass this kind of questionnaire in the absence of warning signs. Then it could result in adverse effects on behavior and ideation.
The study had to be declared as an interventional study according to French law.
SIQ-Fr
Adolescents undergo the SIQ-Fr questionnaire composed of 30 items if \>=15 yo and the SIQ-Fr Junior composed of 15 items if \<15 yo
Suicide screening
Patients of the emergency unit usually do not pass this kind of questionnaire in the absence of warning signs. Then it could result in adverse effects on behavior and ideation.
The study had to be declared as an interventional study according to French law.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Suicide screening
Patients of the emergency unit usually do not pass this kind of questionnaire in the absence of warning signs. Then it could result in adverse effects on behavior and ideation.
The study had to be declared as an interventional study according to French law.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with social protection cover
* in adequation with emergency management
Exclusion Criteria
* minor without parent/gardian at the emergency unit
10 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de la Réunion
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erick Gokalsing, MD
Role: STUDY_DIRECTOR
INSERM U1178
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire de La Réunion
Saint-Pierre, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/CHU/01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.